

Join IGCS-IGCAN virtually on September 25 at 2:00 pm UTC for the 2023 IGCS Gynecologic Cancer Survivor-Caregiver Summit! Register
Advertisement
If you would like to see your event on this calendar, please email education@igcs.org.
Events must be related to the field of gynecologic cancers with the target audience of clinicians, researchers, or advocates (patient/survivors/family members/caregivers).
M
Mon
|
T
Tue
|
W
Wed
|
T
Thu
|
F
Fri
|
S
Sat
|
S
Sun
|
---|---|---|---|---|---|---|
1 event,
![]()
Featured
-
![]()
Featured
Join IGCS-IGCAN virtually on September 25 at 2:00 pm UTC for the 2023 IGCS Gynecologic Cancer Survivor-Caregiver Summit! Register |
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
1 event,
-
![]() Join expert pathologist Dr. Stephanie Skala as she reviews the past and (evolving) present categories of HPV-independent vulvar neoplasia, with emphasis on challenging differential diagnoses and key pathologic features of HPV-independent vulvar intraepithelial neoplasia. Dr. Adrian Suarez, Chair of the IGCS Pathology Workgroup, will serve as moderator. Register Here |
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
1 event,
-
![]() Join us! October Journal Club This session will explore the lead article in our October issue, Sentinel lymph node detection in early-stage ovarian cancer: a systematic review and meta-analysis, along with its accompanying editorial . When? Thursday, October 19, from 11:00-11:45 AM CDT (6:00 PM CEST). Registration is not required. To join the October IJGC chat, simply use this Zoom link to join the journal club at the scheduled time. The featured discussants are Dr. Nuria Agusti, lead author of the article, who will be joined by IJGC Editor-in-Chief Dr. Pedro Ramirez.. We strongly encourage you to join Drs. Agusti, Ramirez—along with your colleagues from around the world—as they assess the article’s findings, evaluate their clinical significance, and consider their potential role in gynecological oncology. |
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
1 event,
|